Back to search

United Kingdom· GB-APID-45261111000001104

Ticagrelor 60mg tablets

A ticagrelor product containing ticagrelor, registered in United Kingdom by Brown & Burk UK Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC B01AC24

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTicagrelor 60mg tabletsATCB01AC24REGISTER NO.GB-APID-4526111100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Ticagrelor is registered in 18 of 19 countries.

Countries holding a registration under ATC B01AC24 (ticagrelor), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Ticagrelor · ATC B01AC24

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ticagrelor costs, country by country.

Normalised to the WHO defined daily dose (0.18 g), the median price runs from $0.68 in United States to $1.97 in Spain — a ×2.9 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Ticagrelor · price per daily dose (0.18 g)

USD · FX 28 Sept 2026

  • ES Spain$1.97
  • CH Switzerland$1.80
  • IT Italy$0.94
  • FR France$0.77
  • US United States$0.68 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ticagrelor
Manufacturer
Brown & Burk UK Ltd
Country
United Kingdom (GB)
ATC code
B01AC24
ATC class
Ticagrelor
Defined daily dose
0.18 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060124643007

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

529 interactions on record for ticagrelor.

Graded by severity as the source publishes them — 76 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ticagrelor · interactions on record

529 records

  • 76 severe
  • 354 moderate
  • 60 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe

39 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ticagrelor in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ticagrelor products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Ticagrelor, Ticagrelor Accord
  • Belgium · Ticagrelor Ab, Ticagrelor Eg
  • Bulgaria · ?????????? Accord, Tilobrastil
  • Cyprus · Brirem, Lacrat
  • Czechia · Atirabo, Atixarso
  • Germany · Ticabril, Ticagrelor
  • Denmark · Lacrat, Ticagrelor Accord
  • Estonia · Agtileq, Atirabo
  • Spain · Lacrat, Ticagrelor Abdi
  • Finland · Ticagrelor Accord, Ticagrelor Avansor
  • France · Ticagrelor Accord, Ticagrelor Arrow
  • Greece · Agilinta, Atixarso
  • Croatia · Atixarso, Greccas
  • Hungary · Atirabo, Atixarso
  • Ireland · Ticagrelor Accord, Ticagrelor Bluefish
  • Iceland · Brilique, Ticagrelor Krka
  • Italy · Auretica, Ticagrelor
  • Liechtenstein · Brilique
  • Lithuania · Atirabo, Atixarso
  • Luxembourg · Ticagelor Eg (Eurogenerics) Nv, Ticagrelor Eg
  • Latvia · Atirabo, Atixarso
  • Malta · Brirem, Croalcril
  • Netherlands · Ticagrelor Abdi, Ticagrelor Accord
  • Norway · Brilique, Ticagrelor Accord
  • Poland · Atirabo, Atixarso
  • Portugal · Brirem, Lacrat Mg
  • Romania · Atixarso, Croalcril
  • Sweden · Auretica, Ecugra
  • Slovenia · Atixarso, Lacrat
  • Slovakia · Atirabo, Atixarso

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d6c74954-9d02-426c-8be2-b6ae201df5fe
GET /v1/drugs/d6c74954-9d02-426c-8be2-b6ae201df5fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "45261111000001104",
  "desc": "Ticagrelor 60mg tablets (Brown & Burk UK Ltd)",
  "form": "Oral tablet",
  "vpid": "32472211000001106",
  "source": "dmd",
  "vtm_id": "777766002",
  "strength": "60 mg",
  "substance": "Ticagrelor",
  "ingredient": "Ticagrelor",
  "supplier_code": "32392811000001109"
}

See everything about ticagrelor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.